Impact of depression on quality of life in people living with human T cell lymphotropic virus type 1 (HTLV-1) in Salvador, Brazil.

dc.creatorCastro, Ana Verena Galvão
dc.creatorBoa-Sorte, Ney Cristian Amaral
dc.creatorKruschewsky, Ramon de Almeida
dc.creatorGrassi, Maria Fernanda Rios
dc.creatorCastro Filho, Bernardo Galvão
dc.date2014-07-25T18:25:14Z
dc.date2014-07-25T18:25:14Z
dc.date2011
dc.date.accessioned2023-09-26T22:41:24Z
dc.date.available2023-09-26T22:41:24Z
dc.identifierGALVÃO-CASTRO, A. V. et al. Impact of depression on quality of life in people living with human T cell lymphotropic virus type 1 (HTLV-1) in Salvador, Brazil. Quality of Life Research, v. 21, n. 9, p. 1545-1550, 2012.
dc.identifier1573-2649
dc.identifierhttps://www.arca.fiocruz.br/handle/icict/8084
dc.identifier10.1007/s11136-011-0066-6
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8881974
dc.descriptionPurpose A previous study found the prevalence of depression in HTLV-1-infected patients to be approximately 30%, but few studies have attempted to correlate depression with quality of life (QOL) in these patients. The present study investigates the association between depression and QOL in people living with HTLV-1. Methods A clinical-epidemiological questionnaire, the Mini International Neuropsychiatric Interview and the WHOQOLBref were applied to 88 HTLV-1-infected patients (32 with TSP/HAM) at the HTLV Center of the Bahiana School of Medicine and Public Health, Salvador, Brazil. Results The prevalence of depression among people living with HTLV-1 was 34.1%. Depression was significantly associated with a poor QOL in the physical, psychological, social relationship and environment domains, when controlling for other variables, such as gender, age, time of knowledge of serological diagnosis and presence of tropical spastic paraparesis/HTLV-1associated myelopathy (TSP/ HAM). Moreover, patients with TSP/HAM experienced a reduction in their QOL in the physical, psychological and environment domains. Conclusion Our results showed that depression negatively affects the quality of life of people living with HTLV-1, regardless of the presence of TSP/HAM. Since it is possible to improve a patient’s QOL by treating depression, psychological evaluations are strongly recommended as a measure to integrate the treatment protocols of HTLV-1 intervention programs.
dc.formatapplication/pdf
dc.languageeng
dc.publisherSpringer
dc.rightsopen access
dc.subjectHuman T-lymphotropic virus 1
dc.subjectDepression
dc.subjectQuality of life
dc.subjectHTLV-1-associated
dc.subjectMyelopathy
dc.subjectDepressão/psicologia
dc.subjectInfecções por HTLV-I/psicologia
dc.subjectVírus 1 Linfotrópico T Humano
dc.subjectQualidade de Vida/psicologia
dc.subjectAdolescente
dc.subjectAdulto
dc.subjectIdoso
dc.subjectIdoso de 80 Anos ou mais
dc.subjectAnálise de Variância
dc.subjectBrasil/epidemiologia
dc.subjectIntervalos de Confiança
dc.subjectEstudos Transversais
dc.subjectDepressão/complicações
dc.subjectFeminino
dc.subjectInfecções por HTLV-I/complicações
dc.subjectHumanos
dc.subjectMasculino
dc.subjectMeia-Idade
dc.subjectPsicometria
dc.subjectQuestionários
dc.subjectEstresse Psicológico
dc.subjectAdulto Jovem
dc.titleImpact of depression on quality of life in people living with human T cell lymphotropic virus type 1 (HTLV-1) in Salvador, Brazil.
dc.typeArticle


Este ítem pertenece a la siguiente institución